Mackay Shields LLC Invests $464,000 in Addus Homecare Co. (ADUS) Stock
Mackay Shields LLC acquired a new position in shares of Addus Homecare Co. (NASDAQ:ADUS) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 8,100 shares of the company’s stock, valued at approximately $464,000. Mackay Shields LLC owned 0.07% of Addus Homecare as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Deutsche Bank AG raised its holdings in Addus Homecare by 51.6% in the fourth quarter. Deutsche Bank AG now owns 40,114 shares of the company’s stock worth $1,393,000 after purchasing an additional 13,655 shares in the last quarter. Millennium Management LLC bought a new position in Addus Homecare in the fourth quarter worth $1,127,000. MetLife Investment Advisors LLC bought a new position in Addus Homecare in the fourth quarter worth $146,000. Monarch Partners Asset Management LLC bought a new position in Addus Homecare in the first quarter worth $423,000. Finally, Campbell & CO Investment Adviser LLC raised its holdings in Addus Homecare by 33.1% in the first quarter. Campbell & CO Investment Adviser LLC now owns 12,273 shares of the company’s stock worth $597,000 after purchasing an additional 3,051 shares in the last quarter. Hedge funds and other institutional investors own 84.81% of the company’s stock.
NASDAQ ADUS opened at $65.25 on Friday. Addus Homecare Co. has a 12 month low of $30.95 and a 12 month high of $71.78. The firm has a market capitalization of $830.22 million, a PE ratio of 40.88, a P/E/G ratio of 2.60 and a beta of -0.39. The company has a debt-to-equity ratio of 0.53, a quick ratio of 3.09 and a current ratio of 3.09.
In other news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of the stock in a transaction on Monday, August 20th. The stock was sold at an average price of $59.00, for a total value of $60,459,247.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 34.80% of the company’s stock.
A number of equities research analysts have recently commented on ADUS shares. Robert W. Baird reissued a “hold” rating and issued a $65.00 target price on shares of Addus Homecare in a research note on Wednesday, August 8th. Oppenheimer increased their target price on Addus Homecare from $50.00 to $72.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 8th. BidaskClub cut Addus Homecare from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 10th. Zacks Investment Research cut Addus Homecare from a “hold” rating to a “strong sell” rating in a research note on Monday, August 13th. Finally, Stephens increased their target price on Addus Homecare from $67.00 to $75.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. Addus Homecare has an average rating of “Buy” and an average target price of $70.33.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Featured Article: Should you buy a closed-end mutual fund?
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.